Allemand C, Valerio AC, Calvo MF, Izbizky G, Lean IM, Terrier F, et al. Impact of the 21-Gene Recurrence Score (Oncotype DX®) on adjuvant therapy decision-making: a collaborative multicenter cohort study from Argentina. MAST [Internet]. 2021 Apr. 5 [cited 2024 Nov. 12];31:1-7. Available from: https://revistamastology.emnuvens.com.br/revista/article/view/312